Gene · 10758
Papers1,982
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 1,982
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| ZC3H12A inhibits tumor growth and metastasis of breast cancer under hypoxic condition via the inactivation of IL-17 signaling pathway. | Cell Cycle | 2024 | 38357935 | PubTator, text mining | PubMed |
| Causal relationship between inflammatory bowel disease and erythema nodosum: A two-sample bidirectional Mendelian randomization study. | Skin Res Technol | 2024 | 38297958 | PubTator, text mining | PubMed |
| Characteristics of mucin hypersecretion in different inflammatory patterns based on endotypes of chronic rhinosinusitis. | Clin Transl Allergy | 2024 | 38282195 | PubTator, text mining | PubMed |
| Mapping the Anti-Cancer Activity of α-Connexin Carboxyl-Terminal (aCT1) Peptide in Resistant HER2+ Breast Cancer. | Cancers (Basel) | 2024 | 38275864 | PubTator, text mining | PubMed |
| Multi-Omics Approach to Improved Diagnosis and Treatment of Atopic Dermatitis and Psoriasis. | Int J Mol Sci | 2024 | 38256115 | PubTator, text mining | PubMed |
| Non-biofilm-forming Staphylococcus epidermidis planktonic cell supernatant induces alterations in osteoblast biological function. | Sci Rep | 2024 | 38245549 | PubTator, text mining | PubMed |
| Cellulose Functionalization Using N-Heterocyclic-Based Leaving Group Chemistry. | Polymers (Basel) | 2024 | 38201814 | PubTator, text mining | PubMed |
| Tumor Necrosis Factor Receptor-Associated Factor 6 and Human Cancer: A Systematic Review of Mechanistic Insights, Functional Roles, and Therapeutic Potential. | J Cancer | 2024 | 38169510 | PubTator, text mining | PubMed |
| Oncogenic lncRNA FAM215A promotes the malignant cell phenotypes of acute myeloid leukemia (AML) cell lines. | J Mol Histol | 2024 | 38165572 | PubTator, text mining | PubMed |
| Therapeutic potential of natural antisense transcripts and various mechanisms involved for clinical applications and disease prevention. | RNA Biol | 2024 | 38090817 | PubTator, text mining | PubMed |
| Decoding Macrophage Subtypes to Engineer Modulating Hydrogels for the Alleviation of Intervertebral Disk Degeneration. | Adv Sci (Weinh) | 2024 | 37939288 | PubTator, text mining | PubMed |
| Identification of Inflammatory Gene in the Congenital Heart Surgery Patients following Cardiopulmonary Bypass via the Way of WGCNA and Machine Learning Algorithms. | Dis Markers | 2023 | 39281206 | PubTator, text mining | PubMed |
| Pharmacogenomics of intravenous immunoglobulin response in Kawasaki disease. | Front Immunol | 2023 | 38259468 | PubTator, text mining | PubMed |
| Crohn's disease and clinical management today: How it does? | World J Methodol | 2023 | 38229938 | PubTator, text mining | PubMed |
| Carotid Artery Stenting Versus Carotid Artery Endarterectomy in Asymptomatic Severe Carotid Stenosis: An Updated Meta-Analysis. | Cureus | 2023 | 38222218 | PubTator, text mining | PubMed |
| Vascular Endothelial Growth Factor A VEGFA Inhibition: An Effective Treatment Strategy for Psoriasis. | Int J Mol Sci | 2023 | 38203230 | PubTator, text mining | PubMed |
| Targeting Interleukin-17 as a Novel Treatment Option for Fibrotic Diseases. | J Clin Med | 2023 | 38202170 | PubTator, text mining | PubMed |
| Current status and development direction of immunomodulatory therapy for intervertebral disk degeneration. | Front Med (Lausanne) | 2023 | 38179277 | PubTator, text mining | PubMed |
| Baseline demographics and disease characteristics of patients with episodic or chronic cluster headache: data from two phase 3 randomized clinical trials in Europe and North America. | Front Neurol | 2023 | 38162453 | PubTator, text mining | PubMed |
| Accelerated Long-Fragment Circular PCR for Genetic Manipulation of Plant Viruses in Unveiling Functional Genomics. | Viruses | 2023 | 38140572 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10758/papers?page=4